5/8/24 19:00 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 0 | 578 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | 0 | 0.00 | 0 | 0 | 0 | 596 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 1,591 | 79.54 | 0 | 20 | 3 | 597 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -9,806 | 490.29 | 0 | -20 | -3 | 597 | D | | | | | | | | | | | | | | |
5/15/23 17:31 | 5/11/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 2 | 0 | 601 | D | | | | | | | | | | | | | | |
5/11/23 17:01 | 5/10/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 178.26 | 0 | 1 | 0 | 602 | D | | | | | | | | | | | | | | |
5/13/22 17:36 | 5/11/22 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 0 | 640 | D | | | | | | | | | | | | | | |
2/22/22 17:00 | 2/18/22 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 141.60 | 0 | 1 | 0 | 640 | D | | | | | | | | | | | | | | |
2/17/22 17:48 | 2/15/22 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -127 | 509.70 | 0 | 0 | 0 | 639 | D | | | | | | | | | | | | | | |
6/1/21 18:00 | 5/28/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 752 | 79.54 | 0 | 9 | 1 | 655 | D | | | | | | | | | | | | | | |
6/1/21 18:00 | 5/28/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -5,319 | 562.26 | 0 | -9 | -1 | 655 | D | | | | | | | | | | | | | | |
5/26/21 17:30 | 5/24/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 795 | 79.54 | 0 | 10 | 2 | 664 | D | | | | | | | | | | | | | | |
5/26/21 17:30 | 5/24/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -5,496 | 549.57 | 0 | -10 | -1 | 664 | D | | | | | | | | | | | | | | |
5/24/21 18:14 | 5/20/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 398 | 79.54 | 0 | 5 | 1 | 664 | D | | | | | | | | | | | | | | |
5/24/21 18:14 | 5/20/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -2,685 | 537.07 | 0 | -5 | -1 | 664 | D | | | | | | | | | | | | | | |
5/20/21 17:33 | 5/18/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 607 | 79.54 | 0 | 8 | 1 | 664 | D | | | | | | | | | | | | | | |
5/20/21 17:33 | 5/18/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -4,030 | 528.02 | 0 | -8 | -1 | 664 | D | | | | | | | | | | | | | | |
5/12/21 19:47 | 5/10/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -277 | 541.02 | 0 | -1 | 0 | 664 | D | | | | | | | | | | | | | | |
2/25/21 19:34 | 2/23/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 67.85 | 0 | 1 | 0 | 664 | D | | | | | | | | | | | | | | |
2/22/21 18:00 | 2/18/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 80 | 79.54 | 0 | 1 | 0 | 663 | D | | | | | | | | | | | | | | |
2/22/21 18:00 | 2/18/21 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -556 | 555.56 | 0 | -1 | 0 | 663 | D | | | | | | | | | | | | | | |
12/11/20 17:00 | 11/2/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.am | -8,958 | 438.43 | 0 | -20 | -3 | 727 | D | | | | | | | | | | | | | | |
11/10/20 19:01 | 11/6/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -3,041 | 470.01 | 0 | -6 | -1 | 720 | D | | | | | | | | | | | | | | |
11/6/20 17:06 | 11/4/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -12,469 | 469.20 | 0 | -27 | -4 | 726 | D | | | | | | | | | | | | | | |
11/4/20 17:25 | 11/2/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -8,958 | 438.43 | 0 | -20 | -3 | 753 | D | | | | | | | | | | | | | | |
8/24/20 17:05 | 8/20/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 1,221 | 67.85 | 0 | 18 | 2 | 820 | D | | | | | | | | | | | | | | |
8/24/20 17:05 | 8/20/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -6,887 | 382.62 | 0 | -18 | -2 | 820 | D | | | | | | | | | | | | | | |
8/20/20 17:00 | 8/18/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 1,357 | 67.85 | 0 | 20 | 2 | 820 | D | | | | | | | | | | | | | | |
8/20/20 17:00 | 8/18/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -7,689 | 384.47 | 0 | -20 | -2 | 820 | D | | | | | | | | | | | | | | |
8/18/20 17:08 | 8/14/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 2,786 | 62.00 | 0 | 45 | 6 | 820 | D | | | | | | | | | | | | | | |
8/18/20 17:08 | 8/14/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -17,124 | 381.05 | 0 | -45 | -5 | 820 | D | | | | | | | | | | | | | | |
5/20/20 17:00 | 5/18/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -11,273 | 296.67 | 0 | -38 | -4 | 820 | I | | | | | | | | | | | | | | |
5/13/20 17:02 | 5/11/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -14,758 | 295.17 | 0 | -50 | -6 | 858 | I | | | | | | | | | | | | | | |
5/12/20 17:11 | 5/8/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 1,310 | 62.00 | 0 | 21 | 2 | 908 | D | | | | | | | | | | | | | | |
5/12/20 17:11 | 5/8/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -6,162 | 291.63 | 0 | -21 | -2 | 908 | D | | | | | | | | | | | | | | |
5/8/20 17:00 | 5/4/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -11,130 | 281.07 | 0 | -40 | -4 | 908 | I | | | | | | | | | | | | | | |
2/27/20 17:02 | 2/25/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 79.54 | 0 | 1 | 0 | 948 | D | | | | | | | | | | | | | | |
2/24/20 17:52 | 2/20/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 1,426 | 62.00 | 0 | 23 | 2 | 947 | M | | | | | | | | | | | | | | |
2/24/20 17:52 | 2/20/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -6,667 | 284.92 | 0 | -23 | -2 | 947 | M | | | | | | | | | | | | | | |
2/24/20 17:51 | 2/19/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.a | -11,493 | 293.62 | 0 | -39 | -4 | 948 | D | | | | | | | | | | | | | | |
2/21/20 17:23 | 2/19/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -11,493 | 293.62 | 0 | -39 | -4 | 948 | D | | | | | | | | | | | | | | |
2/20/20 17:26 | 2/18/20 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -11,474 | 286.84 | 0 | -40 | -4 | 987 | D | | | | | | | | | | | | | | |
11/14/19 17:06 | 11/12/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DH | Senior A | S | -9,146 | 254.05 | 0 | -36 | -3 | 1,065 | D | | | | | | | | | | | | | | |
11/12/19 17:01 | 11/7/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DH | Senior A | S | -9,942 | 263.09 | 0 | -38 | -3 | 1,101 | D | | | | | | | | | | | | | | |
11/6/19 17:16 | 11/4/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DH | Senior A | M.d | 2,467 | 45.84 | 0 | 54 | 5 | 1,139 | D | | | | | | | | | | | | | | |
11/6/19 17:16 | 11/4/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DH | Senior A | S.dm | -21,884 | 276.91 | 0 | -79 | -6 | 1,139 | D | | | | | | | | | | | | | | |
8/12/19 18:00 | 8/8/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB | M.d | 458 | 45.84 | 0 | 10 | 1 | 1,164 | D | | | | | | | | | | | | | | |
8/12/19 18:00 | 8/8/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB | S.d | -2,727 | 272.75 | 0 | -10 | -1 | 1,164 | D | | | | | | | | | | | | | | |
8/7/19 18:30 | 8/5/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB | M.dm | 917 | 45.84 | 0 | 20 | 2 | 1,164 | D | | | | | | | | | | | | | | |
8/7/19 18:30 | 8/5/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB | S.dm | -5,245 | 262.26 | 0 | -20 | -2 | 1,164 | D | | | | | | | | | | | | | | |
5/6/19 18:00 | 5/3/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 1,284 | 45.84 | 0 | 28 | 2 | 1,164 | D | | | | | | | | | | | | | | |
5/6/19 18:00 | 5/3/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -6,973 | 249.03 | 0 | -28 | -2 | 1,164 | D | | | | | | | | | | | | | | |
2/22/19 17:02 | 2/20/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 62.00 | 0 | 2 | 0 | 1,172 | D | | | | | | | | | | | | | | |
2/19/19 18:05 | 2/14/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 2 | 0 | 1,170 | D | | | | | | | | | | | | | | |
2/7/19 17:03 | 2/5/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 2,086 | 43.71 | 0 | 48 | 4 | 1,169 | D | | | | | | | | | | | | | | |
2/7/19 17:03 | 2/5/19 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -9,854 | 206.53 | 0 | -48 | -4 | 1,169 | D | | | | | | | | | | | | | | |
8/30/18 17:04 | 8/28/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 1,311 | 43.71 | 0 | 30 | 3 | 1,201 | D | | | | | | | | | | | | | | |
8/23/18 18:02 | 8/21/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 1,748 | 43.71 | 0 | 40 | 4 | 1,171 | D | | | | | | | | | | | | | | |
8/23/18 18:02 | 8/21/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -7,365 | 245.51 | 0 | -30 | -2 | 1,171 | D | | | | | | | | | | | | | | |
2/20/18 19:29 | 2/16/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 45.84 | 0 | 2 | 0 | 1,161 | D | | | | | | | | | | | | | | |
2/16/18 20:00 | 2/14/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 4 | 0 | 1,159 | D | | | | | | | | | | | | | | |
2/9/18 18:01 | 2/7/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 853 | 38.80 | 0 | 22 | 2 | 1,157 | D | | | | | | | | | | | | | | |
2/9/18 18:01 | 2/7/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -3,905 | 177.52 | 0 | -22 | -2 | 1,157 | D | | | | | | | | | | | | | | |
2/7/18 18:09 | 2/5/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 1,397 | 38.80 | 0 | 36 | 3 | 1,157 | D | | | | | | | | | | | | | | |
2/7/18 18:09 | 2/5/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -6,454 | 179.28 | 0 | -36 | -3 | 1,157 | D | | | | | | | | | | | | | | |
1/11/18 18:11 | 1/9/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 2,095 | 38.80 | 0 | 54 | 5 | 1,157 | D | | | | | | | | | | | | | | |
1/11/18 18:11 | 1/9/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,963 | 165.98 | 0 | -54 | -4 | 1,157 | D | | | | | | | | | | | | | | |
1/5/18 18:00 | 1/3/18 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 485 | 38.80 | 0 | 13 | 1 | 1,157 | D | | | | | | | | | | | | | | |
11/16/17 21:04 | 11/14/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 2,095 | 38.80 | 0 | 54 | 5 | 1,145 | D | | | | | | | | | | | | | | |
11/16/17 21:04 | 11/14/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,128 | 150.52 | 0 | -54 | -5 | 1,145 | D | | | | | | | | | | | | | | |
11/7/17 17:31 | 11/3/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 2,093 | 38.75 | 0 | 54 | 5 | 1,145 | D | | | | | | | | | | | | | | |
11/7/17 17:31 | 11/3/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,171 | 151.32 | 0 | -54 | -5 | 1,145 | D | | | | | | | | | | | | | | |
11/6/17 17:20 | 11/2/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 484 | 38.75 | 0 | 13 | 1 | 1,145 | D | | | | | | | | | | | | | | |
8/30/17 18:28 | 8/28/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 621 | 38.80 | 0 | 16 | 1 | 1,132 | D | | | | | | | | | | | | | | |
8/30/17 18:28 | 8/28/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,960 | 150.79 | 0 | -13 | -1 | 1,132 | D | | | | | | | | | | | | | | |
8/16/17 21:32 | 8/14/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 2,483 | 38.80 | 0 | 64 | 6 | 1,129 | D | | | | | | | | | | | | | | |
8/16/17 21:32 | 8/14/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,990 | 155.00 | 0 | -58 | -5 | 1,129 | D | | | | | | | | | | | | | | |
8/10/17 20:20 | 8/9/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 776 | 38.80 | 0 | 20 | 2 | 1,123 | D | | | | | | | | | | | | | | |
8/10/17 20:20 | 8/9/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,627 | 154.54 | 0 | -17 | -1 | 1,123 | D | | | | | | | | | | | | | | |
8/9/17 18:05 | 8/8/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 776 | 38.80 | 0 | 20 | 2 | 1,120 | D | | | | | | | | | | | | | | |
8/9/17 18:05 | 8/8/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,794 | 155.22 | 0 | -18 | -2 | 1,120 | D | | | | | | | | | | | | | | |
6/1/17 17:40 | 5/30/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 582 | 38.80 | 0 | 15 | 1 | 1,118 | D | | | | | | | | | | | | | | |
6/1/17 17:40 | 5/30/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,182 | 167.82 | 0 | -13 | -1 | 1,118 | D | | | | | | | | | | | | | | |
6/1/17 17:39 | 5/10/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.ad | 1,164 | 38.80 | 0 | 30 | 3 | 1,116 | D | | | | | | | | | | | | | | |
6/1/17 17:39 | 5/10/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.ad | -4,393 | 162.69 | 0 | -27 | -2 | 1,116 | D | | | | | | | | | | | | | | |
5/11/17 18:01 | 5/10/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 1,164 | 38.80 | 33 | 30 | 3 | 1,113 | D | 150 | 86 | 50 | 16 | 5 | 2 | 0 | 0 | 0 | | | | | |
5/11/17 18:01 | 5/10/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,393 | 162.69 | 33 | -27 | -2 | 1,113 | D | 150 | 86 | 50 | 16 | 5 | 2 | 0 | 0 | 0 | | | | | |
5/8/17 18:30 | 5/5/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 1,164 | 38.80 | 33 | 30 | 3 | 1,113 | D | 154 | 89 | 54 | 14 | 6 | 5 | 0 | -1 | 0 | 1 | | | | |
5/8/17 18:30 | 5/5/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,176 | 160.61 | 33 | -26 | -2 | 1,113 | D | 154 | 89 | 54 | 14 | 6 | 5 | 0 | -1 | 0 | 1 | | | | |
2/23/17 18:12 | 2/22/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 2,040 | 39.01 | 33 | 52 | 5 | 1,109 | D | 80 | 98 | 29 | 22 | 18 | 16 | 0 | 0 | 0 | 3 | 7 | | | |
2/23/17 18:12 | 2/22/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,990 | 142.58 | 33 | -35 | -3 | 1,109 | D | 80 | 98 | 29 | 22 | 18 | 16 | 0 | 0 | 0 | 3 | 7 | | | |
2/16/17 19:20 | 2/14/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 6 | 1 | 1,092 | D | 82 | 98 | 28 | 30 | 22 | 19 | 0 | 0 | 0 | 1 | 7 | | | |
2/9/17 17:21 | 2/8/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 966 | 26.66 | 33 | 36 | 3 | 1,088 | D | 85 | 106 | 27 | 30 | 18 | 17 | 17 | -1 | 0 | 0 | 6 | 15 | | |
2/9/17 17:21 | 2/8/17 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -5,134 | 141.63 | 33 | -36 | -3 | 1,088 | D | 85 | 106 | 27 | 30 | 18 | 17 | 17 | -1 | 0 | 0 | 6 | 15 | | |
11/30/16 19:40 | 11/28/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 1,164 | 38.80 | 33 | 30 | 3 | 1,088 | D | 61 | 70 | 36 | 6 | 7 | 10 | 4 | 0 | -3 | -2 | 0 | 24 | | |
11/30/16 19:40 | 11/28/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -3,285 | 119.78 | 33 | -27 | -2 | 1,088 | D | 61 | 70 | 36 | 6 | 7 | 10 | 4 | 0 | -3 | -2 | 0 | 24 | | |
11/10/16 17:02 | 11/9/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 1,066 | 26.66 | 33 | 40 | 4 | 1,086 | D | 48 | 54 | 25 | -2 | -2 | -3 | 2 | 3 | 0 | 4 | 9 | 30 | 50 | |
11/10/16 17:02 | 11/9/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,314 | 107.86 | 33 | -40 | -4 | 1,086 | D | 48 | 54 | 25 | -2 | -2 | -3 | 2 | 3 | 0 | 4 | 9 | 30 | 50 | |
8/4/16 21:43 | 8/4/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 2,132 | 26.66 | 33 | 80 | 8 | 1,086 | D | 71 | 47 | 51 | 27 | 20 | 16 | 16 | 15 | 1 | 2 | 5 | -4 | 29 | |
8/4/16 21:43 | 8/4/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -6,461 | 107.69 | 33 | -60 | -5 | 1,086 | D | 71 | 47 | 51 | 27 | 20 | 16 | 16 | 15 | 1 | 2 | 5 | -4 | 29 | |
2/17/16 17:43 | 2/14/16 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 9 | 1 | 1,066 | D | 12 | -13 | -11 | 3 | -2 | 6 | -2 | 0 | -1 | 0 | 4 | 24 | 58 | 101 |
11/13/15 17:05 | 11/13/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 347 | 17.19 | 33 | 20 | 2 | 1,060 | D | 26 | -12 | -1 | -13 | -11 | -10 | -4 | -5 | 1 | 3 | 3 | 4 | 32 | 63 |
8/19/15 14:54 | 8/17/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 412 | 17.19 | 33 | 24 | 2 | 1,039 | D | 64 | 23 | 0 | 16 | 27 | 18 | 2 | 2 | 0 | -11 | -1 | -13 | -10 | 41 |
8/19/15 14:54 | 8/17/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,161 | 78.45 | 33 | -15 | -1 | 1,039 | D | 64 | 23 | 0 | 16 | 27 | 18 | 2 | 2 | 0 | -11 | -1 | -13 | -10 | 41 |
6/19/15 15:13 | 6/17/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 172 | 17.19 | 33 | 10 | 1 | 1,030 | D | 49 | 2 | -6 | -13 | 3 | -1 | 4 | 2 | -1 | -4 | -6 | 16 | 4 | 30 |
5/5/15 13:05 | 5/1/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 344 | 34.37 | 33 | 10 | 2 | 510 | D | 55 | 2 | -9 | -18 | -15 | -14 | -18 | 0 | -3 | 0 | 1 | 14 | 5 | 30 |
2/19/15 16:19 | 2/17/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 616 | 36.47 | 33 | 17 | 3 | 500 | D | 72 | 25 | 23 | 4 | 7 | -3 | 1 | 0 | 1 | 0 | -1 | -14 | 0 | -10 |
2/18/15 18:30 | 2/14/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 6 | 1 | 483 | D | 70 | 26 | 23 | 2 | 7 | -5 | 0 | -1 | 0 | 0 | -3 | -14 | 0 | -9 |
2/13/15 16:16 | 2/11/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 3,317 | 56.95 | 33 | 58 | 14 | 480 | D | 69 | 28 | 23 | 3 | 6 | -6 | 0 | 3 | -2 | -1 | -4 | -16 | -3 | -15 |
2/13/15 16:16 | 2/11/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -9,054 | 155.45 | 33 | -58 | -11 | 480 | D | 69 | 28 | 23 | 3 | 6 | -6 | 0 | 3 | -2 | -1 | -4 | -16 | -3 | -15 |
1/15/15 17:22 | 1/14/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 817 | 28.66 | 33 | 29 | 6 | 480 | D | 67 | 46 | 22 | 36 | 8 | 9 | 10 | 7 | 1 | 4 | 0 | -4 | -19 | -14 |
1/15/15 17:22 | 1/14/15 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,496 | 157.68 | 33 | -29 | -6 | 480 | D | 67 | 46 | 22 | 36 | 8 | 9 | 10 | 7 | 1 | 4 | 0 | -4 | -19 | -14 |
12/5/14 08:42 | 12/3/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 1,347 | 30.60 | 33 | 44 | 10 | 480 | D | 61 | 42 | 13 | 18 | 18 | -2 | -1 | 1 | 0 | 0 | -1 | 2 | -12 | -5 |
12/5/14 08:42 | 12/3/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,306 | 148.49 | 33 | -29 | -6 | 480 | D | 61 | 42 | 13 | 18 | 18 | -2 | -1 | 1 | 0 | 0 | -1 | 2 | -12 | -5 |
11/7/14 11:08 | 11/5/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 831 | 28.66 | 33 | 29 | 7 | 465 | D | 55 | 34 | 11 | 14 | 24 | 22 | 2 | 2 | -1 | 5 | 1 | 5 | -11 | -3 |
11/7/14 11:08 | 11/5/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -4,160 | 143.45 | 33 | -29 | -6 | 465 | D | 55 | 34 | 11 | 14 | 24 | 22 | 2 | 2 | -1 | 5 | 1 | 5 | -11 | -3 |
8/5/14 12:21 | 8/4/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 287 | 28.66 | 33 | 10 | 2 | 465 | D | 43 | 28 | 16 | -3 | -5 | -5 | -5 | 0 | 0 | 0 | 0 | 12 | 24 | 16 |
7/31/14 12:55 | 7/30/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 344 | 34.37 | 33 | 10 | 2 | 455 | D | 44 | 29 | 12 | 0 | -4 | -5 | -3 | -2 | -2 | 0 | -2 | 13 | 29 | 13 |
2/19/14 17:05 | 2/14/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 10.43 | 33 | 10 | 2 | 445 | D | 44 | 38 | 31 | 18 | 19 | 11 | 7 | 2 | 1 | 0 | -1 | 2 | 2 | 25 |
2/4/14 15:08 | 1/31/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 3,869 | 41.30 | 33 | 94 | 27 | 439 | D | 29 | 15 | 10 | 1 | 5 | 1 | -5 | -4 | 6 | 11 | 16 | 19 | 16 | 44 |
2/4/14 15:08 | 1/31/14 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -9,142 | 112.46 | 33 | -81 | -16 | 439 | D | 29 | 15 | 10 | 1 | 5 | 1 | -5 | -4 | 6 | 11 | 16 | 19 | 16 | 44 |
11/27/13 16:17 | 11/25/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 3,749 | 41.65 | 33 | 90 | 27 | 426 | D | 50 | 13 | 26 | 10 | -1 | -4 | -2 | -3 | 0 | 0 | 2 | 20 | 23 | 43 |
11/27/13 16:17 | 11/25/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,232 | 105.30 | 33 | -78 | -15 | 426 | D | 50 | 13 | 26 | 10 | -1 | -4 | -2 | -3 | 0 | 0 | 2 | 20 | 23 | 43 |
11/14/13 13:45 | 11/12/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 3,749 | 41.65 | 33 | 90 | 28 | 414 | D | 48 | 18 | 22 | 11 | 5 | 2 | -3 | -3 | 1 | 1 | -3 | 17 | 20 | 44 |
11/14/13 13:45 | 11/12/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,315 | 106.36 | 33 | -78 | -16 | 414 | D | 48 | 18 | 22 | 11 | 5 | 2 | -3 | -3 | 1 | 1 | -3 | 17 | 20 | 44 |
11/6/13 08:33 | 11/4/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 56.95 | 33 | 2 | 0 | 403 | D | 53 | 16 | 24 | 12 | 11 | 3 | 4 | 1 | 0 | -2 | -4 | 8 | 20 | 33 |
10/28/13 09:31 | 10/24/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 3,749 | 41.65 | 33 | 90 | 29 | 401 | D | 39 | 8 | 18 | 7 | 8 | 3 | -1 | 1 | 3 | 3 | 1 | 8 | 21 | 33 |
10/28/13 09:31 | 10/24/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -8,159 | 104.36 | 33 | -78 | -16 | 401 | D | 39 | 8 | 18 | 7 | 8 | 3 | -1 | 1 | 3 | 3 | 1 | 8 | 21 | 33 |
2/19/13 19:20 | 2/14/13 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 7 | 2 | 389 | D | 18 | 4 | 0 | 2 | -4 | -8 | -3 | -2 | 0 | 0 | -1 | -6 | 4 | 37 |
12/20/12 16:26 | 12/18/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 414 | 17.14 | 33 | 24 | 7 | 384 | D | 33 | 29 | 2 | -2 | 3 | 2 | 2 | 0 | -1 | -3 | -1 | -4 | -7 | 8 |
12/20/12 16:26 | 12/18/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,745 | 96.08 | 33 | -18 | -5 | 384 | D | 33 | 29 | 2 | -2 | 3 | 2 | 2 | 0 | -1 | -3 | -1 | -4 | -7 | 8 |
11/28/12 14:19 | 11/27/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 343 | 17.14 | 33 | 20 | 6 | 378 | D | 40 | 33 | 7 | -2 | -4 | -2 | 3 | 0 | -1 | 0 | 1 | 0 | -10 | 13 |
11/28/12 14:19 | 11/27/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,390 | 92.67 | 33 | -15 | -4 | 378 | D | 40 | 33 | 7 | -2 | -4 | -2 | 3 | 0 | -1 | 0 | 1 | 0 | -10 | 13 |
11/15/12 13:09 | 11/13/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 343 | 17.14 | 33 | 20 | 6 | 373 | D | 42 | 22 | 3 | -2 | -9 | -8 | -5 | 0 | 0 | 3 | 7 | 2 | -3 | 19 |
11/15/12 13:09 | 11/13/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,349 | 89.92 | 33 | -15 | -4 | 373 | D | 42 | 22 | 3 | -2 | -9 | -8 | -5 | 0 | 0 | 3 | 7 | 2 | -3 | 19 |
11/14/12 13:57 | 11/9/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 41.94 | 33 | 2 | 1 | 368 | D | 41 | 25 | 4 | -1 | -8 | -8 | -5 | 0 | -1 | 2 | 6 | 2 | -4 | 18 |
11/8/12 13:04 | 11/6/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 667 | 38.34 | 33 | 17 | 5 | 366 | D | 50 | 28 | 4 | 4 | -7 | -5 | -3 | -2 | -3 | -4 | 1 | 1 | -6 | 17 |
11/8/12 13:04 | 11/6/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,260 | 94.06 | 33 | -13 | -4 | 366 | D | 50 | 28 | 4 | 4 | -7 | -5 | -3 | -2 | -3 | -4 | 1 | 1 | -6 | 17 |
10/26/12 10:45 | 10/24/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 343 | 17.14 | 33 | 20 | 6 | 362 | D | 59 | 34 | 9 | 7 | -4 | -3 | -2 | -2 | 0 | -2 | -5 | 0 | -11 | 13 |
10/26/12 10:45 | 10/24/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,446 | 96.42 | 33 | -15 | -4 | 362 | D | 59 | 34 | 9 | 7 | -4 | -3 | -2 | -2 | 0 | -2 | -5 | 0 | -11 | 13 |
10/17/12 14:02 | 10/15/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 767 | 38.34 | 33 | 20 | 6 | 357 | D | 54 | 41 | 12 | 6 | 1 | -1 | -1 | 1 | 0 | -1 | -8 | -5 | -8 | 9 |
10/17/12 14:02 | 10/15/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,451 | 96.76 | 33 | -15 | -4 | 357 | D | 54 | 41 | 12 | 6 | 1 | -1 | -1 | 1 | 0 | -1 | -8 | -5 | -8 | 9 |
9/17/12 14:11 | 9/13/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 343 | 17.14 | 33 | 20 | 6 | 352 | D | 69 | 34 | 18 | 13 | 11 | 6 | 3 | 2 | -3 | -1 | -3 | -4 | -8 | -2 |
9/17/12 14:11 | 9/13/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,489 | 99.25 | 33 | -15 | -4 | 352 | D | 69 | 34 | 18 | 13 | 11 | 6 | 3 | 2 | -3 | -1 | -3 | -4 | -8 | -2 |
8/10/12 14:29 | 8/8/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 343 | 17.14 | 33 | 20 | 6 | 347 | D | 57 | 23 | 4 | 2 | -4 | 0 | 2 | 0 | 3 | 5 | 10 | 0 | 4 | 8 |
8/10/12 14:29 | 8/8/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,342 | 89.45 | 33 | -15 | -4 | 347 | D | 57 | 23 | 4 | 2 | -4 | 0 | 2 | 0 | 3 | 5 | 10 | 0 | 4 | 8 |
8/3/12 15:10 | 8/1/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 20 | 6 | 342 | D | 46 | 10 | 1 | -1 | -4 | -5 | 0 | -2 | 3 | 2 | 9 | 8 | 7 | 11 |
8/3/12 15:10 | 8/1/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,321 | 88.06 | 33 | -15 | -4 | 342 | D | 46 | 10 | 1 | -1 | -4 | -5 | 0 | -2 | 3 | 2 | 9 | 8 | 7 | 11 |
7/27/12 14:06 | 7/25/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 20 | 6 | 337 | D | 49 | 6 | 1 | 1 | 0 | -8 | -4 | 0 | 2 | 0 | 7 | 9 | 11 | 11 |
7/27/12 14:06 | 7/25/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,309 | 87.28 | 33 | -15 | -4 | 337 | D | 49 | 6 | 1 | 1 | 0 | -8 | -4 | 0 | 2 | 0 | 7 | 9 | 11 | 11 |
2/16/12 19:33 | 2/14/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 7 | 2 | 332 | D | 64 | 12 | 14 | 22 | 11 | 1 | 3 | 3 | -1 | -1 | -5 | -4 | 4 | 3 |
1/19/12 10:41 | 1/17/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 20 | 7 | 328 | D | 42 | 19 | 6 | 21 | 13 | 7 | 6 | 4 | 1 | 3 | 6 | 4 | 9 | 11 |
1/19/12 10:41 | 1/17/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,269 | 82.81 | 33 | -15 | -4 | 328 | D | 42 | 19 | 6 | 21 | 13 | 7 | 6 | 4 | 1 | 3 | 6 | 4 | 9 | 11 |
1/5/12 10:44 | 1/4/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 20 | 7 | 323 | D | 46 | 15 | -1 | 18 | 12 | 6 | 2 | 1 | 0 | 3 | 10 | 10 | 22 | 21 |
1/5/12 10:44 | 1/4/12 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,178 | 78.54 | 33 | -15 | -4 | 323 | D | 46 | 15 | -1 | 18 | 12 | 6 | 2 | 1 | 0 | 3 | 10 | 10 | 22 | 21 |
12/20/11 14:04 | 12/19/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 20 | 7 | 318 | D | 41 | 2 | -3 | -2 | 0 | 1 | 2 | -1 | 2 | 7 | 16 | 15 | 30 | 31 |
12/20/11 14:04 | 12/19/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,105 | 73.64 | 33 | -15 | -5 | 318 | D | 41 | 2 | -3 | -2 | 0 | 1 | 2 | -1 | 2 | 7 | 16 | 15 | 30 | 31 |
11/18/11 13:55 | 11/17/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 252 | 12.60 | 33 | 20 | 7 | 313 | D | 41 | 15 | -7 | 1 | 7 | 0 | 0 | 3 | -3 | -7 | -1 | 19 | 14 | 24 |
11/18/11 13:55 | 11/17/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,120 | 74.70 | 33 | -15 | -5 | 313 | D | 41 | 15 | -7 | 1 | 7 | 0 | 0 | 3 | -3 | -7 | -1 | 19 | 14 | 24 |
10/6/11 13:23 | 10/4/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 504 | 12.60 | 33 | 40 | 15 | 308 | D | 38 | 10 | -13 | -15 | -10 | -8 | -5 | -1 | 2 | 5 | 6 | 16 | 27 | 45 |
10/6/11 13:23 | 10/4/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -1,957 | 65.24 | 33 | -30 | -9 | 308 | D | 38 | 10 | -13 | -15 | -10 | -8 | -5 | -1 | 2 | 5 | 6 | 16 | 27 | 45 |
9/8/11 16:47 | 9/7/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 252 | 12.60 | 33 | 20 | 7 | 298 | D | 55 | 35 | 0 | 6 | -6 | 0 | 2 | 0 | -5 | -2 | -9 | -3 | 9 | 29 |
9/8/11 16:47 | 9/7/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,140 | 76.03 | 33 | -15 | -5 | 298 | D | 55 | 35 | 0 | 6 | -6 | 0 | 2 | 0 | -5 | -2 | -9 | -3 | 9 | 29 |
7/29/11 09:58 | 7/27/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 252 | 12.60 | 33 | 20 | 7 | 293 | D | 67 | 42 | 14 | 3 | 14 | 5 | 5 | -4 | 0 | -9 | -8 | -14 | 0 | 8 |
7/29/11 09:58 | 7/27/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,253 | 83.50 | 33 | -15 | -5 | 293 | D | 67 | 42 | 14 | 3 | 14 | 5 | 5 | -4 | 0 | -9 | -8 | -14 | 0 | 8 |
7/18/11 17:39 | 7/14/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 252 | 12.60 | 33 | 20 | 7 | 288 | D | 71 | 29 | 15 | 0 | 5 | 5 | -1 | 0 | 2 | 12 | 1 | -7 | 7 | 17 |
7/18/11 17:39 | 7/14/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,191 | 79.41 | 33 | -15 | -5 | 288 | D | 71 | 29 | 15 | 0 | 5 | 5 | -1 | 0 | 2 | 12 | 1 | -7 | 7 | 17 |
6/22/11 13:51 | 6/21/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 252 | 12.60 | 33 | 20 | 8 | 283 | D | 72 | 19 | 5 | -1 | -8 | -2 | 4 | 4 | 0 | 2 | 8 | -1 | -3 | 25 |
6/22/11 13:51 | 6/21/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,124 | 74.96 | 33 | -15 | -5 | 283 | D | 72 | 19 | 5 | -1 | -8 | -2 | 4 | 4 | 0 | 2 | 8 | -1 | -3 | 25 |
6/8/11 16:22 | 6/6/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 504 | 12.60 | 33 | 40 | 17 | 278 | D | 66 | 20 | 11 | -5 | -8 | -7 | -6 | -3 | 1 | 2 | 10 | 3 | 2 | 17 |
6/8/11 16:22 | 6/6/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.dm | -2,213 | 73.75 | 33 | -30 | -10 | 278 | D | 66 | 20 | 11 | -5 | -8 | -7 | -6 | -3 | 1 | 2 | 10 | 3 | 2 | 17 |
3/4/11 14:04 | 3/3/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 100 | 38.34 | 33 | 3 | 1 | 267 | D | 166 | 43 | 38 | 21 | 13 | 5 | 2 | 2 | -1 | -3 | 0 | -4 | 1 | 8 |
2/16/11 17:41 | 2/14/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 7 | 3 | 265 | D | 135 | 46 | 37 | 23 | 13 | 7 | 5 | 3 | 0 | -2 | -4 | 2 | -1 | 13 |
1/6/11 17:20 | 1/5/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 31 | 50 | 24 | 261 | D | 109 | 27 | 10 | 11 | 6 | -3 | -3 | 0 | -1 | 1 | 8 | 14 | 16 | 15 |
1/6/11 17:20 | 1/5/11 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,756 | 67.67 | 31 | -41 | -13 | 261 | D | 109 | 27 | 10 | 11 | 6 | -3 | -3 | 0 | -1 | 1 | 8 | 14 | 16 | 15 |
12/7/10 13:13 | 12/6/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 27 | 50 | 25 | 252 | D | 140 | 26 | 8 | 15 | 8 | 4 | 1 | 1 | 1 | 6 | 4 | 17 | 11 | 12 |
12/7/10 13:13 | 12/6/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,694 | 66.16 | 27 | -41 | -14 | 252 | D | 140 | 26 | 8 | 15 | 8 | 4 | 1 | 1 | 1 | 6 | 4 | 17 | 11 | 12 |
11/9/10 11:08 | 11/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 29 | 50 | 26 | 243 | D | 80 | 21 | -4 | 7 | 3 | 0 | 4 | 3 | 0 | 1 | 7 | 20 | 31 | 17 |
11/9/10 11:08 | 11/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,504 | 61.47 | 29 | -41 | -14 | 243 | D | 80 | 21 | -4 | 7 | 3 | 0 | 4 | 3 | 0 | 1 | 7 | 20 | 31 | 17 |
10/6/10 13:29 | 10/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 24 | 50 | 27 | 233 | D | 22 | 29 | 8 | -1 | 13 | 6 | 4 | 2 | -1 | -2 | -3 | 10 | 26 | 7 |
10/6/10 13:29 | 10/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,543 | 62.43 | 24 | -41 | -15 | 233 | D | 22 | 29 | 8 | -1 | 13 | 6 | 4 | 2 | -1 | -2 | -3 | 10 | 26 | 7 |
9/8/10 13:05 | 9/7/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 26 | 50 | 29 | 224 | D | 5 | 15 | 2 | -6 | -5 | 1 | 3 | 1 | 0 | 1 | 8 | 15 | 35 | 31 |
9/8/10 13:05 | 9/7/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,340 | 57.46 | 26 | -41 | -15 | 224 | D | 5 | 15 | 2 | -6 | -5 | 1 | 3 | 1 | 0 | 1 | 8 | 15 | 35 | 31 |
8/6/10 12:03 | 8/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 33 | 50 | 30 | 215 | D | 10 | 17 | 18 | -7 | -4 | -2 | -2 | 0 | -1 | -5 | -2 | 2 | 24 | 27 |
8/6/10 12:03 | 8/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,428 | 59.63 | 33 | -41 | -16 | 215 | D | 10 | 17 | 18 | -7 | -4 | -2 | -2 | 0 | -1 | -5 | -2 | 2 | 24 | 27 |
7/7/10 14:36 | 7/6/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 25 | 50 | 32 | 205 | D | 23 | 34 | 12 | 5 | -1 | -7 | -3 | -1 | 5 | 6 | 0 | 3 | 16 | 30 |
7/7/10 14:36 | 7/6/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,475 | 60.77 | 25 | -41 | -17 | 205 | D | 23 | 34 | 12 | 5 | -1 | -7 | -3 | -1 | 5 | 6 | 0 | 3 | 16 | 30 |
6/9/10 14:57 | 6/7/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 28 | 50 | 34 | 196 | D | 21 | 38 | 17 | 9 | -7 | -4 | -1 | -5 | 1 | 5 | 2 | -6 | 8 | 20 |
6/9/10 14:57 | 6/7/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,505 | 61.52 | 28 | -41 | -17 | 196 | D | 21 | 38 | 17 | 9 | -7 | -4 | -1 | -5 | 1 | 5 | 2 | -6 | 8 | 20 |
5/6/10 17:21 | 5/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 630 | 12.60 | 33 | 50 | 37 | 187 | D | 26 | 61 | 29 | 29 | 15 | 8 | -1 | -1 | -4 | 4 | -3 | -6 | -6 | 24 |
5/6/10 17:21 | 5/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,670 | 65.57 | 33 | -41 | -18 | 187 | D | 26 | 61 | 29 | 29 | 15 | 8 | -1 | -1 | -4 | 4 | -3 | -6 | -6 | 24 |
4/6/10 14:34 | 4/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 882 | 12.60 | 27 | 70 | 65 | 177 | D | 16 | 65 | 20 | 8 | 10 | 2 | 1 | 1 | 0 | 3 | 14 | 5 | 7 | 37 |
4/6/10 14:34 | 4/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,360 | 57.96 | 27 | -41 | -19 | 177 | D | 16 | 65 | 20 | 8 | 10 | 2 | 1 | 1 | 0 | 3 | 14 | 5 | 7 | 37 |
3/9/10 16:16 | 3/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.dm | 856 | 13.48 | 32 | 63 | 75 | 148 | D | 8 | 94 | 14 | 10 | 0 | 6 | 8 | 1 | 0 | 1 | 4 | 8 | 4 | 37 |
3/9/10 16:16 | 3/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -2,720 | 55.78 | 32 | -49 | -25 | 148 | D | 8 | 94 | 14 | 10 | 0 | 6 | 8 | 1 | 0 | 1 | 4 | 8 | 4 | 37 |
2/17/10 15:54 | 2/14/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 0 | 0.00 | 33 | 5 | 4 | 133 | D | -6 | 56 | 6 | 4 | -1 | -6 | 6 | 6 | 0 | -2 | 6 | 21 | 5 | 45 |
2/12/10 13:49 | 2/11/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 189 | 12.60 | 33 | 15 | 13 | 131 | D | -9 | 53 | 3 | -2 | -5 | -9 | 2 | 4 | 3 | 2 | 9 | 28 | 9 | 45 |
2/12/10 13:49 | 2/11/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -620 | 51.04 | 33 | -12 | -9 | 131 | D | -9 | 53 | 3 | -2 | -5 | -9 | 2 | 4 | 3 | 2 | 9 | 28 | 9 | 45 |
2/9/10 10:01 | 2/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | M.d | 315 | 12.60 | 33 | 25 | 24 | 128 | D | -11 | 44 | -2 | -3 | -7 | -16 | -14 | -2 | 1 | 7 | 12 | 29 | 20 | 50 |
2/9/10 10:01 | 2/5/10 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | DO | CB,P,CEO | S.d | -1,031 | 50.16 | 33 | -21 | -14 | 128 | D | -11 | 44 | -2 | -3 | -7 | -16 | -14 | -2 | 1 | 7 | 12 | 29 | 20 | 50 |